Clinical Trials Logo
NCT number NCT03497897
Study type Interventional
Source Novartis
Contact Novartis Pharmaceuticals
Phone +41613241111
Email Novartis.email@novartis.com
Status Not yet recruiting
Phase Phase 2
Start date May 28, 2018
Completion date November 1, 2019

Clinical Trial Summary

The main purpose of this study is to assess preliminary efficacy and safety of LYS006 in patients with moderate to severe inflammatory acne and to determine if LYS006 has an adequate clinical profile for further clinical development.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms